University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Hospital vs. Cell Phone Number Follow-Up Randomization Study

Not Applicable

Completed

Conditions: Subject Follow-up

Interventions: Other: Hospital Landline Phone Calls
Other: Private Cell Phone Calls

First Posted Date: 2012-06-15

Last Posted Date: 2016-08-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 400

Registration Number: NCT01620827

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock

Phase 2

Completed

Conditions: Traumatic Shock

Interventions: Drug: Vasopressin

First Posted Date: 2012-06-05

Last Posted Date: 2019-05-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 101

Registration Number: NCT01611935

Locations: 🇺🇸
Hospital at the Unversity of Pennyslvania, Philadelphia, Pennsylvania, United States

Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Obesity

Interventions: Behavioral: Lifestyle Modification for Type 2 Diabetes Prevention
Other: Nutrition and Physical Activity

First Posted Date: 2012-06-01

Last Posted Date: 2012-06-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 52

Registration Number: NCT01610219

Locations: 🇺🇸
University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine, Philadelphia, Pennsylvania, United States

Ghrelin Dose Finding In Frail Elderly

Phase 2

Completed

Conditions: The Frailty Syndrome

Interventions: Drug: Ghrelin Group 1
Drug: Ghrelin Group 2

First Posted Date: 2012-05-24

Last Posted Date: 2019-12-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT01605435

Locations: 🇺🇸
Clinical and Translational Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)

Phase 4

Completed

Conditions: HIV Dementia

Interventions: Drug: placebo
Drug: Atorvastatin (generic Lipitor)

First Posted Date: 2012-05-16

Last Posted Date: 2020-11-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT01600170

Locations: 🇺🇸
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Eating Behaviors Among Weight-Discordant Siblings

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: Feeding study

First Posted Date: 2012-05-15

Last Posted Date: 2012-05-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 94

Registration Number: NCT01598389

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Microparticles in Scuba Divers With Decompression Sickness

Completed

Conditions: Decompression Sickness
Dysbarism

First Posted Date: 2012-04-30

Last Posted Date: 2016-08-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1

Registration Number: NCT01587209

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery

Phase 2

Completed

Conditions: Prescription Opiate/Medication Dependence

Interventions: Drug: Vivitrol

First Posted Date: 2012-04-30

Last Posted Date: 2024-10-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 72

Registration Number: NCT01587196

Locations: 🇺🇸
University of Pennsylvania Addiction Treatment Research Center, Philadelphia, Pennsylvania, United States

The Effects of Treating Obese and Lean Patients With Sleep Apnea

Not Applicable

Completed

Conditions: Obesity
Sleep Apnea

Interventions: Device: Positive Airway Pressure During Sleep (ResMed S9 Elite)
Other: Usual Care

First Posted Date: 2012-04-16

Last Posted Date: 2019-07-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 450

Registration Number: NCT01578031

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Phase 4

Completed

Conditions: Psoriasis
Cardiovascular Disease

Interventions: Drug: Placebo Injection
Other: NB-UVB phototherapy
Drug: Adalimumab (Humira)

First Posted Date: 2012-03-13

Last Posted Date: 2018-05-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 97

Registration Number: NCT01553058

Locations: 🇺🇸
National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
University of California, Davis Health System, Sacramento, California, United States

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy